Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04487717Active Not Recruiting

Prospective Assessment of nProfiler® 1 on Prognosis and Chemotherapy Response for Gastric Cancer

Role: lead

NCT06521528Active Not Recruiting

A Pilot Clinical Study to Evaluate the Feasibility of Using the SPC Test

Role: lead

NCT04600518Completed

Single Patient Classifier (SPC) Prediction for Stage II and III Advanced Gastric Cancer

Role: lead

All 3 trials loaded